Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010031/S933

Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M

Medtronic Cardiac Rhythm Disease Management · Decision date Oct 5, 2026

MEDTECHLEDGER EXPLANATIONP010031/S933

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-05 for PMA supplement P010031/S933 from Medtronic Cardiac Rhythm Disease Management. The supplement is a 30-Day Notice filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded statement of scope is to qualify new manufacturing equipment. The supplement sits under P010031 and covers the Cobalt MRI CRT-D, Cobalt XT MRI CRT-D and Crome M families, with model numbers listed for the Cobalt devices.

The device category is an automatic implantable cardioverter defibrillator with cardiac resynchronization (CRT-D), specialty Cardiovascular, product code NIK. This action concerns manufacturing equipment qualification for the listed CRT-D systems; it is not a new approval of the underlying PMA or a change to the devices' cleared labeling. The source record includes no documents, so the specific equipment, affected manufacturing site and any conditions attached to OK30 are not stated here and remain unknown.

Whether the equipment change alters device performance, sterility or supply is not addressed in the available fields, so no clinical or regulatory conclusion beyond the recorded decision can be drawn.

FDA approval order statement

to qualify new manufacturing equipment
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010031/S933
Regulatory pathway
PMA supplement
Product code
NIK
Decision code
OK30
Decision date
Oct 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D).

Product code
NIK
FDA device class
3

For the original device and its historical approval scope, see PMA P010031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010031 · Original PMA

    CONCERTO/INSYNC SENTRY/INSYNC MAXIMO IMPLANTABLE CARDIOVASCULAR DEFIBRILLATORS WITH CARDIAC RESYNCHICNIZATION

  2. P010031/S933 received

    Application receipt date recorded by FDA.

  3. P010031/S932 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  4. P010031/S933 · FDA decision

    30-Day Notice

  5. P010031/S934 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  6. P010031/S931 · Related supplement

    Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome M

Timeline entries are records held by MedtechLedger for P010031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010031

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records